We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Tag: therapeutics

Finance

Sangamo Therapeutics Q4 Earnings Preview

Sangamo Therapeutics Q4 Earnings Preview: A Comprehensive Overview 1. Introduction to Sangamo Therapeutics and the Significance of Q4 Earnings Sangamo Therapeutics, a pioneering biotechnology company, is...
Mark Gardner -
Finance

Analysts Are Bullish on Top Healthcare Stocks: Prelude Therapeutics (PRLD), Corbus Pharmaceuticals (CRBP)

Introduction The healthcare sector continues to be a beacon of optimism, with recent bullish sentiments from analysts on two notable companies: Prelude Therapeutics (PRLD) and...
Mark Gardner -
Finance

Voyager Therapeutics price target lowered to $10 from $12 at Wells Fargo

Wells Fargo Analyst Adjusts Voyager Therapeutics' Price Target: A Comprehensive Analysis Introduction to the Analyst's Move In a recent move, Wells Fargo analyst Yanan Zhu adjusted...
Mark Gardner -
Finance

Barclays Sticks to Their Sell Rating for Prelude Therapeutics (PRLD)

Barclays Analyst Peter Lawson Maintains Sell Rating on Prelude Therapeutics Barclays analyst Peter Lawson recently reaffirmed his Sell rating on Prelude Therapeutics (PRLD), setting a...
Mark Gardner -
Finance

RBC Capital Sticks to Its Buy Rating for Knight Therapeutics (KHTRF)

Knight Therapeutics: A Promising Investment with Analysts and Insiders Aligning on Growth Potential Knight Therapeutics, a biopharmaceutical company, has recently gained attention from analysts and...
Mark Gardner -
123Page 1 of 3

Popular Articles

Subscribe for updates

To be updated with all the latest news, offers and special announcements.

Discover News Write Ups, your trusted source for comprehensive and engaging news coverage. From regional UK stories to global news, our team of skilled journalists delivers reliable information in an easy-to-read format. Stay informed, stay engaged, and explore the stories that matter to you.

© NewsWriteUps.com

Address

The Outset, Sankey Street, Warrington, Cheshire WA1 1NN

Phone

01925595705